Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Proposes September Deadline For Sunscreen Rule...And May Stick To It

Executive Summary

Meeting proposed deadlines on regulatory agenda actions, such as finalizing OTC monographs, could be a higher priority for FDA under its new management
Advertisement

Related Content

FDA re-targets final sunscreen rule for May
FDA re-targets final sunscreen rule for May
FDA Nonprescription Office Expects Progress On Sunscreen Monograph
Sharfstein Takes “Acting” Title Literally, Starting FDA Overhaul
Sharfstein Takes “Acting” Title Literally, Starting FDA Overhaul
Industry Groups Burned About Proposed Sunscreen Labeling Requirements
Advertisement
UsernamePublicRestriction

Register

RS016186

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel